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Abstract
Influenza A viruses (IAV) bind to sialic-acids at cellular surfaces and enter cells by using endocytotic routes. There is evidence
that this process does not occur constitutively but requires induction of specific cellular signals, including activation of PI3K
that promotes virus internalization. This implies engagement of cellular signaling receptors during viral entry. Here, we
present first indications for an interplay of IAV with receptor tyrosine kinases (RTKs). As representative RTK family-members
the epidermal growth factor receptor (EGFR) and the c-Met receptor were studied. Modulation of expression or activity of
both RTKs resulted in altered uptake of IAV, showing that these receptors transmit entry relevant signals upon virus binding.
More detailed studies on EGFR function revealed that virus binding lead to clustering of lipid-rafts, suggesting that
multivalent binding of IAV to cells induces a signaling platform leading to activation of EGFR and other RTKs that in turn
facilitates IAV uptake.
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Introduction
Influenza A viruses are enveloped viruses that possess a single
strand RNA genome with negative orientation. As cell obligate
parasites IAV have to enter host cells to ensure efficient replication
and propagation by abusing the cellular machinery. Like other
enveloped viruses IAV enter the cell by endocytotic routes [1].
The particles are internalized via clathrin-mediated or clathrin
and calveolin-independent endocytosis [2]. IAV binds to sialic acid
residues at the host cell surface via the viral glycoprotein
hemagglutinin (HA). However, these structures possess no
signaling capacity and are, thus, not sufficient to induce host cell
signaling, which is required to sort the virus particles into specific
endocytotic routes. Therefore, it was hypothesized quite early on
that engagement of specific signaling-receptors may be required
for efficient viral entry [3]. However, the identity of such receptors
remained enigmatic.
Among the signaling components, which are induced upon IAV
binding are the protein kinase C (PKC) [4], the extracellular
signal-regulated kinase ERK [5] and the phosphatidylinositol-3
kinase (PI3K) [6]. PKC has been implicated to be involved in
entry processes of various viral pathogens such as rhabdoviruses,
alphaviruses, poxviruses, herpesviruses, and IAV [7,8]. Upon IAV
infection, PKC is activated upon attachment of the viral HA to the
cell-surface [4]. Activation of the isoform PKCbII results in sorting
of the virus particles into the late endosomes [8]. In addition,
activation of PI3K and ERK1/2 has been described during entry
of human cytomegalovirus [9,10]. PI3K activation was not only
shown to be crucial for IAV entry [6] but also has been
demonstrated to regulate vesicular uptake, and trafficking of
Ebola viruses [11]. However, it is still elusive, how signaling events
are initiated upon early IAV binding and how these signals are
transmitted to mediate PKC, ERK and PI3K activation.
A major mechanism that transforms extracellular signals to
intracellular PI3K and ERK1/2 activation is the engagement of
receptor tyrosine kinases (RTKs). Among the family of RTKs the
group of epidermal growth factor receptors, consisting of four
members (EGF-, ErbB2-, ErbB3 and ErbB4-receptors) are well
studied (reviewed in [12]). Parallels between sorting pathways for
the epidermal growth factor receptor (EGFR) and IAV have been
identified. Both use endocytotic mechanisms during internaliza-
tion and require protein ubiquitinylation to be sorted into the
vacuolar protein synthesis machinery [13]. Since it was shown that
IAV and EGFR were sorted into the same population of late
endosomes [2], we hypothesized that RTKs, such as the EGFR
may be involved to induce IAV uptake. In this study we
investigated the role of EGFR and c-Met, the receptor of
hepatocyte growth factor, as candidate RTKs, in IAV entry
processes. Broad inhibition of tyrosine kinases by small molecule
inhibitors as well as specific EGFR or c-Met inhibition via siRNA
mediated knock-down resulted in reduced virus uptake and
subsequently to reduced progeny virus titers. Attachment of IAV
resulted in clustering of plasma membrane lipids, comparable to
EGF stimulation. Our data suggest that IAV is a multivalent agent
that, upon binding to sialic acids, is able to cluster and activate
EGFR and other RTKs to form a lipid raft-based signaling
platform. This leads to receptor-mediated signaling events, such as
PI3K/Akt activation, which enhances IAV uptake.
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Inhibition of tyrosine kinase activity leads to impaired IAV
uptake into cells
To examine the role of RTKs in IAV entry processes, we
treated human A549 lung epithelial cells with the broad-range
tyrosine kinase inhibitor genistein prior to infection. To detect
incoming virus particles cells were infected with a high multiplicity
of infection (MOI) and the viral HA was visualized by
immunofluorescence (IF) (Figure 1A) as previously described [8].
While in solvent treated cells virus particles were internalized into
endosomes 30 min post infection (p.i.) (Figure 1A, upper left panel
and z-axis view), in genistein treated cells a completely different
staining pattern was observed. A major portion of virus particles
appeared to remain stuck to the cell surface (Figure 1A, upper
right panels, white arrow heads and z-axis view). To demonstrate
the specific inhibitory effect of genistein on the endocytosis of
RTKs, we compared the internalization of the EGFR and
transferrin (supplementary Figure S1). The EGFR is a represen-
tative and ubiquitously expressed family member of RTKs, while
transferrin is a glycoprotein, which is internalized independently
from RTKs [14]. While transferrin uptake was not affected by
genistein treatment, as evidenced by colocalization of transferrin
and the early endosomal antigen 1 (EEA1), EGF-induced EGFR
internalization was decreased, resulting in a reduced colocalization
of EGFR and EEA1 (Figure S1, upper panel). To independently
confirm the IF data (Figure 1A), IAV internalization was visualized
by detection of virion-associated matrix protein (M1) in Western-
blot analysis (Figure 1B) as described by Eierhoff and colleagues
[15]. Selective detection of M1 of internalized IAV particles was
achieved by applying an acidic washing step before cell lysis to
remove attached but not yet internalized virions [15].
M1 protein levels were reduced about 77% in genistein treated
cells in comparison to solvent treated cells (Figure 1B) indicating
inefficient viral uptake. This correlated with significantly reduced
progeny virus titers for the avian virus strain A/FPV/Bratislava/
79 (FPV) and the human virus strain A/Puerto Rico/8/34 (PR8)
(Figure 1C). The level of titer reduction of about 70% perfectly
correlated with the decrease of EGFR internalization with the
given concentration of genistein (Figure S1, upper panel). To
further confirm these results we also used a RTK inhibitor mix
targeting several kinases such as VEGFR, IGFR, PDGFR, EGFR
and c-Met. Again virus titers were decreased up to 75% (Figure 1E)
concomitant with reduced internalization, as evidenced by 80%
lower amount of M1 protein (Figure 1D).
Increased EGFR abundance enhances IAV uptake
Our results so far indicated that efficient IAV uptake requires, at
least in part, tyrosine kinases and probably RTK activity. Based on
identification of concurrent endocytotic routes for EGFR and IAV
[2], we were prompted to investigate the role of EGFR as a
candidate RTK in IAV entry processes.
Cells were transfected with a tagged form of the EGFR. Albeit
only a moderate expression of the exogenous EGFR was
detectable (Figure 2B), these enhanced levels of the receptor were
sufficient to result in a significant increase of virion-associated M1
protein 15 min to 60 min p.i., in comparison to vector transfected
cells (Figure 2A). This indicates accelerated virus internalization in
the presence of increasing amounts of EGFR. Again, enhanced
IAV internalization correlated well with an increase in virus yields
from cells over-expressing EGFR (Figure 2B). To further confirm
an involvement of EGFR in IAV uptake, we employed the mouse
embryonic fibroblast cell line NIH3T3 that does not express
endogenous EGFR and the NIH3T3-Her14 cell line stably
expressing EGFR [16]. Functionality of the NIH3T3-Her14 cell
line was verified in Western-blot analysis: only in NIH3T3-Her14
cells, expression of a functional EGFR that was activated by the
ligand was detectable (Figure 2C). While upon infection of control
cells virus-associated M1 protein was barely detectable, a strong
increase of M1 levels was observed in Her14 expressing cells,
indicative of strongly enhanced virus uptake (Figure 2D). Further,
NIH3T3 wt and NIH3T3-Her14 cells were infected with the IAV
strains PR8 and FPV and progeny virus titers were monitored over
a time period of 32 hours (Figure 2E). IAV replicated well in both
cell types, however, in NIH3T3-Her14 cells virus titers were
enhanced at every time point analysed. This observation
strengthens the previous findings that virus internalisation was
more efficient in EGFR expressing NIH3T3 cells.
Impaired expression, or activation of EGFR and c-Met
results in reduced internalization of IAV
So far our results indicated that over-expression of the EGFR
enhances early IAV uptake. To further foster these findings, an
EGFR blocking antibody was employed at different time points
pre- and post infection. The results showed that only when EGFR
was inhibited at early stages during virus infection, progeny virus
titers were significantly reduced (Figure 3A). Inhibition of EGFR
30 min p.i., or later showed no effects anymore. These findings
were further supported by an approach using EGFR specific
siRNA. Efficient EGFR knock-down was confirmed in Western-
blot analysis (Figure 3B and 3C). Down-regulation of EGFR
resulted in reduced internalization of virus particles as evidenced
by reduced levels of virion-associated M1 protein in cells
(Figure 3B) and significantly reduced progeny virus titers
(Figure 3C).
Removal of the EGFR from the cell-surface can also be
achieved by prolonged stimulation with EGF, causing ligand
induced internalization and degradation [17,18]. To blunt IAV-
accessible EGFR from cell surfaces, cells were pre-treated with
EGF 90 min before infection. EGF-induced EGFR degradation
was monitored in Western-blot analysis (Figure 3D, E). As
expected, virion-associated M1 protein levels were strongly
reduced in cells where the EGFR was degraded (Figure 3D). This
is also reflected by significantly decreased progeny virus titers upon
Author Summary
Obligate intracellular pathogens such as influenza viruses
have to enter the host cell to ensure replication and
propagation. This process implies the penetration of the
plasma membrane. To overcome this membrane barrier
viruses have evolved several strategies to abuse the
cellular signal-transduction machinery upon binding to
specific receptors. Influenza viruses enter the host cell by
different endocytotic routes upon attachment to sialic acid
residues that serve as direct receptors at the cellular
surface. Nevertheless, sialic acids are not able to transmit
signals across the plasma membrane, indicating the
necessity of additional signaling receptors. In the present
study we address the central question, how cells sense
influenza virus attachment and how the immediate
signaling events upon virus binding are transmitted across
the plasma membrane to induce influenza virus internal-
isation. We show that influenza virus attachment results in
a re-arrangement of signaling platforms in the plasma
membrane, thereby activating receptor tyrosine kinases
that serve as signaling mediators to accomplish virus
internalisation.
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of EGFR expression affects the basal EGFR activity and therefore
EGFR signaling, phosphorylation of EGFR and phosphorylation
of an EGFR regulated down-stream target, ERK2 was monitored
in a control experiment (Figure S2). Neither EGFR knock-down
nor over-expression of EGFR could induce EGFR or ERK2
phosphorylation (Figure S2). Thus, IAV internalization can be
modulated in both directions either by EGFR over-expression or
by EGFR knock-down or blockade. Furthermore, the down-
regulation of the EGFR expression level did not change the uptake
of transferrin, an RTK independent ligand (Figure S1, lower
panel), pointing to the specificity of the RTK-regulated endocy-
tosis.
We now addressed the question, whether the effects on IAV
entry were exclusively regulated by EGFR or whether other RTKs
exhibit similar functions on IAV internalization as suggested by
the previous experiments (Figure 1). Indeed, we were able to
identify the cellular receptor for hepatocyte growth factor, c-Met
as another RTK family member, which is able to interfere with
IAV internalization. SiRNA-mediated knock-down of c-Met and
inhibition of kinase activity resulted in impaired IAV uptake
(Figure 4A, C). The decrease of M1 levels as well as the reduction
of progeny virus titers (Figure 4B, D) were similar to that observed
upon EGFR inhibition or knock-down, respectively (Figure 3B, C).
Moreover, additional experiments using the RTK inhibitor mix
indicated that the extent of reduction in virus titers depends on the
number of RTKs that were simultaneously affected by specific
inhibitors (Figure 4F) or siRNAs prior to infection (Figure 4E).
These data indicate that RTK-mediated entry of IAV is not
restricted to specific binding and activation of a particular receptor
kinase, such as the EGFR but involves a more general mode of
activation of several RTKs including the c-Met receptor. We now
investigated this mechanism further using the EGFR as a model.
Attachment of IAV to cells results in clustering of plasma-
membrane lipids
Since EGFR is localized in lipid raft domains [19] and lipid rafts
may function as signaling platforms [20], we examined raft
organisation in the context of EGF stimulation or viral
attachment. The main components of lipid rafts are cholesterol
and sphingolipids [21] and these structures are enriched in
glycosyl-phosphatidylinositol-linked proteins, signaling molecules
as well as the ganglioside GM1. GM1 serves as lipid raft marker.
Upon stimulation of EGFR GM1 enriched microdomains
undergo endocytosis via clathrin-dependent and clathrin-indepen-
dent mechanisms [22,23]. To evaluate whether lipid rafts are
clustered upon IAV attachment, we compared GM1 localization
upon EGF stimulation or IAV infection of A549 cells. GM1,
which is present in the cellular membrane, was labelled using
FITC-conjugated Choleratoxin beta subunit (CtxB). In untreated
cells GM1 was detected in an even distribution in the cell
membrane (Figure 5A, left panel). In EGF treated cells GM1 was
reorganized to form distinct patches at the membrane, indicating
lipid-cluster formation (Figure 5A, middle panel). Interestingly, the
overall staining pattern of GM1 in IAV infected cells (Figure 5A,
right panel) closely resembled that observed upon EGF treatment
(Figure 5A, middle panel).
To determine whether EGFR is present in lipid rafts upon IAV
infection and whether attaching IAV particles are localized to lipid
rafts, co-patching experiments were performed. A549 cells were
infected or left untreated. Subsequently GM1 was visualized with
FITC-conjugated CtxB. Co-patching was performed by cross-
linking of CtxB through a rabbit antiserum either in combination
to an EGFR-specific or an H7-HA-specific mouse antiserum. The
EGFR could be clearly co-patched with GM1, as evidenced in a
more than 70% overlap of staining that indicates colocalization
(Figure 5B, left panel). This is in the same range as detected for
IAV particles (Figure 5B, middle panel). Both, viruses and EGFR
were also found to be located in close proximity at the cell surface,
here an overlapping staining of more than 80% was observed
(Figure 5B, right panel). Thus, the EGFR and attaching IAV
particles are localized to lipid raft domains that are reorganized
upon infection.
To confirm the requirement of lipid rafts for efficient IAV entry,
we depleted cholesterol from the lipid rafts by using methyl-b-
cyclodextrin (MCD). First, the efficacy of cholesterol depletion was
investigated. Lipid rafts were visualized by detecting GM1 with
FITC-conjugated CtxB and raft microdomains were cross-linked
using a polyclonal rabbit antiserum against CtxB. After patching
of lipid rafts, GM1 was visible in distinct areas at the cell surface
(Figure 5C, upper left panel), whereas in MCD treated cells the
lipid raft clusters were resolved and GM1 was found to be evenly
distributed over the membrane (Figure 5C, upper right panel). To
assess a functional link between lipid rafts and IAV internalization,
raft microdomains were disrupted by MCD treatment prior to
infection. Reduced M1 levels in MCD treated cells indeed
indicated impaired virus internalization in the absence of properly
formed lipid raft clusters (Figure 5D, lane 4). Impaired virus
uptake provoked by cholesterol depletion prior to infection led to
significantly reduced virus titers (Figure 5E).
The EGFR undergoes endocytosis in response to IAV
attachment
So far our results indicate the presence of EGFR and IAV
particles in close proximity within lipid rafts upon viral
attachment. We now examined whether the EGFR is also
activated upon virus binding to the cell surface. If this would be
the case one would expect that the EGFR undergoes endocytosis
upon IAV attachment, similar to EGF stimulation. Cells were
either left untreated (Figure 6A, left panel), stimulated with EGF
(Figure 6A, middle panel) or infected with IAV (Figure 6A, right
panel). In an additional set, sialic acids were removed by sialidase
treatment to prevent virus attachment (Figure 6A, lower panel). In
IF-microscopy we observed EGFR located at the plasma
Figure 1. Tyrosine kinase activity is required for efficient uptake of IAV. (A, B, C) A549 cells were treated with genistein (50 mM, [+]) or (D, E)
a mixture of several RTK inhibitors (each 10 mM, [+] see experimental procedures) or the solvent control (DMSO,[2]) respectively for 60 min at 37uCo r
over night prior to infection. (A) Upon genistein treatment, cells were either mock infected or infected with influenza virus A/FPV/Bratislava/79 (H7N7)
(FPV; MOI=100) for further 30 min. Virus particles were visualized in immunofluorescence (IF) microscopy, via a hemagglutinin (HA)-specific rabbit
antiserum and an Alexa 594-conjugated chicken anti-rabbit IgG. The nuclei were stained with DAPI. The white arrowheads point to virus particles
lining at the cell border. (B, D) After infection with influenza virus A/Puerto-Rico/8/34 (H1N1) PR8 (MOI=8) for further 30 min, an acidic wash (PBS,
pH 1.3, 4uC) was performed before cell-lysis. Internalized virus particles were visualized with a M1 monoclonal antibody in Western-blot (WB) analysis.
Equal protein load was verified by ERK2 detection. The relative amount of M1 was quantified (B and D lower panels). Relative M1 densities are
expressed as mean 6SD of three independent experiments. (C, E) Cells were infected with FPV or PR8 (MOI=4) for 8 h; upon the virus-attachment
period an acidic wash (PBS-HCl, pH 5.5) was included. Progeny virus titers were determined by standard plaque assays. Data represent mean values of
at least three independent experiments 6SD. Statistical significance was assessed by student’s t-test (*) p,0.05, (**) p,0.005. See also Figure S1.
doi:10.1371/journal.ppat.1001099.g001
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PLoS Pathogens | www.plospathogens.org 4 September 2010 | Volume 6 | Issue 9 | e1001099Figure 2. EGFR is involved in IAV uptake. (A, B) An EGFR expressing construct was transfected into A549 cells. (A) After 24 h cells were infected
with PR8 (MOI=4) for the indicated time points. An acidic wash (PBS, pH 1.3, 4uC) was performed before cell-lysis to remove not internalized virus
particles. In WB analysis M1 and ERK2 were detected. The relative amount of M1 was quantified (A, lower panel). Relative M1 densities are expressed
as mean 6SD of three independent experiments. (B) Cells were infected with FPV (MOI=0.5, left panel) or PR8 (MOI=0.1, right panel) for 8 h; upon
the attachment period an acidic wash (PBS-HCl, pH 5.5) was included. Progeny virus titers were determined by standard plaque assays. Data
represent mean values of at least three independent experiments 6SD. Statistical significance was assessed by student’s t-test (*) p,0.05. In WB
analysis EGFR expression level of uninfected cells was detected. (C, D) NIH3T3 wild-type (wt) and NIH3T3 EGFR expressing (HER14) cells were
incubated with (C) EGF (30 ng ml
21, 10 min, 37uC) or (D) were infected with PR8 (MOI=4) for the indicated times. Upon infection an acidic wash (PBS,
pH 1.3, 4uC) was performed before cell-lysis. WBs were probed with the indicated antibodies (pEGFR (Y1068) is the autophosphorylation site in the
EGFR at tyrosine 1068). (E) NIH3T3 wild-type (wt) and NIH3T3-Her14 (HER14) cells were infected with PR8 and FPV (MOI=1) for the indicated times.
Upon the attachment period an acidic wash (PBS-HCl, pH 5.5) was included. Progeny virus titers were determined by standard plaque assays. Data
represent mean values of three independent experiments 6SD. See also Figure S2.
doi:10.1371/journal.ppat.1001099.g002
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PLoS Pathogens | www.plospathogens.org 5 September 2010 | Volume 6 | Issue 9 | e1001099Figure 3. EGFR knock-down impairs efficient uptake of IAV into A549 cells. (A) A549 cells were treated with an EGFR-specific antibody (5 mg
ml
21) or mouse serum at the indicated times before and during infection with FPV (MOI=0.5) for 8 h. Progeny virus titers were determined by
standard plaque assays; virus yields of serum treated cells were arbitrarily set as 100%. Calculation of virus titers revealed 5.65610
5 PFU ml
21
(61.2610
5) for -30 min pre-incubation, 10610
5 PFU ml
21 (61610
5) for anti EGFR- and for serum pre-incubation. Statistical significance was assessed
EGFR Promotes Influenza Virus Entry
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the receptor was internalized upon EGF stimulation (Figure 6A,
upper middle panel), a process that was independent from sialidase
treatment (Figure 6A, lower middle panel). Upon IAV infection of
cells both, virus particles and the EGFR were internalized
(Figure 6A, upper right panel). While at the time of virus entry
EGFR and IAV are colocalized (Figure 5B) IAV and EGFR
colocalization is not detectable anymore at 30 min p.i.. This
observation presumably point to a distinct sorting of IAV and
EGFR. In sialidase treated cells neither virus attachment nor
EGFR internalization was visible (Figure 6A, lower right panel),
indicating that IAV attachment promotes EGFR internalization in
a sialic acid dependent manner. These results could be confirmed
by FACS analysis of cell surface associated EGFR. Sialidase
treated or untreated cells were stimulated either with EGF or
infected with IAV. Again, the internalization of EGFR upon EGF
stimulation was not sensitive to sialidase treatment, as evidenced
by reduced amounts of surface located EGFR. IAV infection also
triggered EGFR endocytosis albeit to a lower extend and in a
sialidase dependent manner (Figure 6B). According to the kinetic
of EGFR internalization, EGF treatment leads to a strong
decrease in the first 15 min turning to a plateau later (Figure 6B).
In contrast, IAV attachment reduced the number of EGFR at the
cellular surface in a linear fashion (Figure 6B), which matches the
linear increase of internalization detected for IAV (Figure 6C).
These results point to a similar internalization kinetic for IAV and
EGFR during infection. Further analysis of the internalization
pathways utilized by IAV and EGFR in infected cells revealed that
both equally depend on clathrin and caveolin-1 expression.
SiRNA-mediated knock-down of either clathrin heavy chain
(CHC) or caveolin-1 (CAV-1) (verified by Western blot,
Figure 6D) in IAV infected cells resulted in a decrease of cell-
surface EGFR of about 10% or 15%, respectively, at 30 min p.i.
(Figure 6E). Upon simultaneous knock-down of CHC and CAV-1
the amount of EGFR located at the cellular surface, was only
reduced about 3% after infection (Figure 6E) indicating that
internalisation is greatly dependent on these two factors. In
another experimental setting it could be shown that the
dependency on CHC and CAV-1 is similar for EGF stimulated
and virus-induced EGFR internalisation (Figure 6F). The
measurement of internalized IAV particles verified the strong
dependency of IAV on CHC and CAV-1 during IAV uptake
processes (Figure 6G). Upon knock-down of CAV-1 or CHC
expression IAV internalization was reduced and concurrent
knock-down of CAV-1 and CHC inhibited IAV uptake, further
(Figure 6G).
IAV attachment to A549 cells induces EGFR kinase
activity
Together, the data so far suggest that IAV attachment leads to
clustering of lipid rafts and stimulates internalization of EGFR.
Considering the requirement of EGFR kinase activity for EGF-
induced EGFR endocytosis [24,25] these results imply that virus
attachment should induce EGFR kinase activation. Since previous
studies revealed the requirement of PI3K activity for efficient IAV
uptake [6], we focussed on tyrosine 1068 (Tyr1068) of EGFR, a
known EGF inducible autophosphorylation site that serves as a
docking site for the protein Gab1 leading to PI3K recruitment
[26]. Tyr1068 readily gets phosphorylated in response to EGF
stimulation of A549 cells, concomitant with phosphorylation of the
PI3K effector Akt at Ser473, a site that is targeted in a strictly
PI3K dependent manner (Figure 7A, lane 2 and lane 4). Both,
phosphorylation of the EGFR and Akt could be blocked by
PD153035, a specific EGFR kinase inhibitor (Figure 7A, lane 3).
This indicates that PI3K activation via EGF in A549 cells requires
EGFR kinase activity and autophosphorylation at Tyr1068.
The next set of experiments should elucidate whether EGFR
activity is induced upon IAV infection and whether EGFR activity
is required for virus uptake. Western-blot analysis revealed that
EGFR was time-dependently phosphorylated upon IAV infection
(Figure 7B). Virus-induced EGFR phosphorylation occurred
concomitant with accumulation of virus-associated M1
(Figure 7C, lane 3 to 5) and was dependent on viral binding to
sialic acids as evidenced by disappearance of the phospho-signal
upon pre-treatment with sialidase (Figure 7C, lane 7 to 9).
Inhibition of the EGFR kinase by an EGFR specific inhibitor
resulted in reduced M1 abundance indicating the requirement of
kinase activity for virus internalization (Figure 7D). This was also
visible by reduced infection upon inhibiton of the EGFR kinase
prior to infection applying either the PD-inhibitor or Lapatinib, an
additional EGFR inhibitor (data not shown). In line with these
data recruitment of the regulatory subunit p85 of PI3K to the
EGFR was observed in response to viral attachment (Figure 7E,
lane 2). In addition, enhanced EGFR activity that was achieved by
pulse stimulation with EGF for 10 min resulted in enhanced virus
uptake (Figure 7F, lane 2). This effect was reversible by the EGFR
kinase specific inhibitor PD153035 (Figure 7G, lane 4). Taken
together, our results clearly indicate that active EGFR promotes
the IAV entry processes. The data further suggest that EGFR gets
activated by formation of raft signaling domains due to multivalent
binding of the viral HAs to sialic acids at the cell surface.
Concomitant, we could show that IAV induced EGFR-signaling,
which regulates PI3K activation, only occurs in cells with intact
raft domains (Figure S3, lane 2). In accordance with previous
studies [27,28] the aberrant phosphorylation of EGFR by MCD
was not transmitted into the downstream signaling leading to the
activation of PI3K (Figure S3, lane 4 and 5). Thus, EGFR
phosphorylation is not sufficient for full induction of downstream
signaling, but rather depends on functional raft domains. To
analyse whether such a clustered binding of sialic acids is sufficient
to activate the EGFR kinase, we made use of lectins. These
compounds bind sialic acids in a multivalent fashion and cause
hemagglutination similar to IAV [29]. The lectin Sambucus nigra
agglutinin (SNA) specifically recognizes Siaa2-6Gal, while Maackia
amurensis agglutinin II (MAAII) is specific for Siaa2-3Gal linkage
[30,31]. SNA staining revealed that Siaa2-6Gal is present on A549
while Siaa2-3Gal was detected with MAAII to lower amounts
(Figure 7H, upper panel). Accordingly binding of SNA resulted in
an activation of EGFR kinase (Figure 7H, lower panel, lane 2),
by student’s t-test (*) p,0.05. (B, C) A549 cells were transfected with a control siRNA or a specific siRNA targeting the EGFR. 48 h post transfection
cells were infected with (B) PR8 (MOI=4) for 30 min or (C) PR8 or FPV (MOI=4) for 8 h. (C) Upon the attachment period an acidic wash (PBS-HCl,
pH 5.5) was included. (D, E) A549 cells were incubated with EGF (100 ng ml
21) 90 min before infection with (D) PR8 (MOI=4) for 30 min or (E) PR8 or
FPV (MOI=4) for 8 h. (B, D) Before cell-lysis an acidic wash (PBS-HCl, pH 1.3, 4uC) was performed and cell-lysates were analysed in WB. Relative M1
densities are expressed as mean 6SD of three independent experiments. (C, E) Progeny virus yields were determined by standard plaque assays. Data
represent mean values of three independent experiments 6SD. Statistical significance was assessed by student’s t-test (*) p,0.05. EGFR knock-down
was verified by WB before infection (C and E, lower panels). Cells were transiently transfected with an EGFR construct during RNAi mediated knock-
down (B) or 24 h prior to EGF induced EGFR degradation (D). See also Figure S1 and S2.
doi:10.1371/journal.ppat.1001099.g003
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activity (Figure 7H, lower panel, lane 3).
Discussion
Influenza viruses are cell obligate parasites and thus, are strongly
dependent on the cellular machinery of their host. In case of IAV the
initial steps of infection comprise the binding to sialic acids at the
cellularmembrane and subsequent internalization ofthe virus particles.
The requirement of active cellular signaling processes for internaliza-
tion, such as activation of PI3K [6], suggested that IAV penetration of
the cellular membrane is not a constitutive process, but is supported by
immediate signaling events induced by viral binding to the cell surface.
Requirement of post-attachment factors to achieve efficient
endocytosis of IAV has already been discussed previously [3]. In
the present study we could identify the EGFR and the c-Met
receptor as candidate RTKs that are activated upon attachment
and promote IAV internalization.
RTKs came into focus as prime candidates for signaling
receptors involved in IAV uptake, since kinases such as PI3K or
ERK1/2, which are known to be activated directly upon virus
binding [5,6] are targeted by these receptors. To unravel the
mechanism of RTK function during IAV uptake, we exemplarily
studied the EGFR as an abundantly expressed signaling-receptor
model that is able to induce PI3K activity. We could not only
demonstrate that the EGFR kinase is activated by IAV attachment
Figure 4. The RTK c-Met is involved in IAV internalization. (A, B) A549 cells were incubated with a c-Met kinase inhibitor (50 mM) at 37uC over
night or (C, D) were transfected with control or c-Met specific siRNA 48 h prior to infection. Internalized influenza virus particles were visualized as
described in Figure 1B upon infection with the influenza virus strain PR8 (A) (MOI=8) or (C) (MOI=4). Progeny virus titers were determined 8 h upon
infection with the influenza A virus strain FPV (B, D) (MOI=4). Data represent mean values of three independent experiments 6SD. Statistical
significance was assessed by student’s t-test (*) p,0.05, c-Met knock-down was verified by WB before infection (D, lower panel). (E) A549 cells were
transfected either with a control siRNA or with specific siRNAs against c-Met and EGFR, as indicated 48 h prior to infection. Progeny virus titers were
determined 8 h upon infection with FPV or PR8 (MOI=4). Data represent mean values of three independent experiments 6SD. Statistical significance
was assessed by student’s t-test (*) p,0.05, (**) p,0.005. EGFR and c-Met knock-down was verified by WB before infection (E, lower panels). (F) A549
cells were treated with an inhibitor mix containing the indicated RTK inhibitors (each 10 mM, see experimental procedures) or the solvent control
(DMSO) 16 hours prior to infection at 37uC. Subsequently cells were infected with FPV (MOI=4) for 8 h and progeny virus titers were determined.
Data represent mean values of three independent experiments 6SD. Statistical significance was assessed by student’s t-test (*) p,0.05.
doi:10.1371/journal.ppat.1001099.g004
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PLoS Pathogens | www.plospathogens.org 8 September 2010 | Volume 6 | Issue 9 | e1001099Figure 5. Attachment of IAV clusters plasma-membrane lipids. (A, B) A549 cells were infected with FPV (MOI=100), stimulated with EGF
(100 ng ml
21) or left untreated for 1 h at 4uC. Subsequently cells were incubated with the FITC-conjugated Choleratoxin beta subunit (CtxB)
(30 mgm l
21) for 1 h at 4uC to visualize ganglioside M1 (GM1). (B) FPV was visualized by detection of HA via an HA-specific rabbit antiserum and an
Alexa 594-conjugated chicken anti-rabbit IgG (right panel) or via an H7-HA-specific mouse antiserum and a Texas-Red conjugated goat anti-mouse
IgG (middle panel). EGFR was detected by an EGFR-specific mouse antiserum followed by a Texas-Red conjugated goat anti-mouse IgG (left panel) or
a Alexa 488-conjugated chicken anti-mouse IgG (right panel). For co-patching analysis CtxB was cross-linked by a rabbit antiserum against CtxB. Cells
were examined by confocal laser scanning-microscopy. The colocalization was quantified as described in the experimental procedure section. (C, D, E)
A549 cells were incubated with methyl-b-cyclodextrin (MCD) (40 mgm l
21) for 1 h at 37uC and subsequently washed with PBS to withdraw MCD. (C)
Cells were stained for GM1 with FITC-conjugated CtxB for 1 h at 4uC and subsequently incubated with rabbit antiserum against CtxB. (D) Cells were
infected with PR8 (MOI=4) for 1 h at 37uC; an acidic wash (PBS-HCl; pH 1.3, 4uC) was performed. In WB analysis M1 and ERK2 were detected. Relative
M1 densities are expressed as mean values 6SD of at least three independent experiments. (E) Cells were infected with FPV or PR8 (MOI=4); upon
the attachment period an acidic wash (PBS-HCl, pH 5.5) was performed. Progeny virus titers were determined by plaque assays. Data represent mean
values of three independent experiments 6SD. Statistical significance was assessed by student’s t-test (*) p,0.05, (**) p,0.005.
doi:10.1371/journal.ppat.1001099.g005
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PLoS Pathogens | www.plospathogens.org 9 September 2010 | Volume 6 | Issue 9 | e1001099Figure 6. IAV attachment induces EGFR endocytosis. (A) Upon treatment with sialidase (6 sialidase; 0.01 units ml
21, 3 h, 37uC), A549 cells
were infected with FPV (MOI=100) or were stimulated with EGF, each for 1 h at 4uC and 30 min at 37uC. An EGFR-specific mouse antiserum and Alexa
488-conjugated chicken anti-mouse IgG as well as a HA-specific rabbit antiserum and an Alexa 594-conjugated chicken anti-rabbit IgG were
employed. Cells were examined by IF microscopy. (B, C) A549 cells were infected with FPV (MOI=100) or (B) incubated with EGF (30 ng ml
21) for 1 h
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initial IAV uptake into host cells. The same holds true for the c-
Met receptor tyrosine kinase. These results indicated that
activation of RTKs such as EGFR and c-Met is a crucial step
for efficient IAV entry, rather than a by-standing effect. The
findings further imply that activation is not mediated by viral
engagement of a particular receptor kinase but is a more general
phenomenon that affects several RTKs. This is additionally
supported by results of a recent siRNA screening study, which
identified the fibroblast growth factor receptors FGFR 1, 2 and 4
as RTKs involved in very early steps of viral infection [32].
EGF stimulation induces aggregation of lipid rafts, serving as
signaling platforms to initiate signal transduction and EGFR
internalization [33]. Our data provide indirect experimental
evidence for similarities between EGF and IAV induced lipid
cluster formation (Figure 5A). Therefore it seems likely that IAV
leads to a concentration of signaling modules within clustered lipid
rafts and thereby inducing signal transduction, as shown for other
ligands [34]. Such a mechanism was also suggested for EGFR
activation [35]. Even if previous results by Whittaker and
colleagues [36,37] demonstrated that cholesterol depletion from
the virus envelope but not from cellular membrane resulted in
reduced virus infection, in our hands cholesterol depletion of A549
cells impaired efficient IAV internalization (Figure 5D). These
divergent results are probably due to different experimental
settings, the usage of divers cell-lines and various influenza virus
strains. The most essential difference is referred to the distinct
treatment of cells with MCD. While Whittaker and colleagues
added MCD during both, the virus adsorption and incubation
periods [36], in our experimental settings cells were pre-incubated
with MCD for 60 min before infection and MCD was removed
afterwards. Based on our results we hypothesize that IAV induce
raft cluster formation by the multivalent binding of viral HA to
sialic acids. The clustered rafts serve as signaling platforms to
facilitate virus internalization. Sialic acid-modified GM1, analysed
in the present study (Figure 5) is in particular a suitable interaction
partner for viral HA and probably triggers arrangement of
signaling platforms (Figure 8). However, we observed only partial
colocalization of IAV and GM1 at the cell surface. These results
point to multiple internalization mechanisms used by IAV, even
independent from raft microdomains.
Formation of clusters upon IAV attachment probably brings
raft resident signaling molecules such as RTKs in close proximity,
which are subsequently activated (Figure 8). A remaining
challenge concerned the mechanism of EGFR mediated IAV
uptake into the host cells. Based on our results we considered a
facilitated IAV entry accompanied by down-regulation of signaling
receptors that presumably would promote co-endocytosis of IAV
into the host cell. Indirect evidence was provided by the
observation of an attachment dependent internalization of EGFR
and IAV triggered down-regulation of EGFR by onset of
endocytotic processes (Figure 6A, B). Several phosphorylated
tyrosine residues at the trans-phosphorylation site of the EGFR
were described as binding sites for factors involved in the ligand-
induced removal of the EGFR from the cell surface. Among these
factors are c-Cbl [38,39] AP2 and Epsin15 [40,41] and PI3K [42].
Furthermore, the data indicate an equal contribution of clathrin-
and caveolin dependent endocytosis during IAV uptake and IAV
induced EGFR internalization (Figure 6E, G). Based on these
results we concluded that clathrin- and caveolin-1 are additional
regulatory factors, which mediate IAV internalization in cooper-
ation with RTKs. In this study we identified an IAV induced
generation of a binding site for PI3K at the EGFR. Upon IAV
infection Tyr1068 at the EGFR was phosphorylated, which
generates a putative binding site for the regulatory subunit of
PI3K, p85 [43]. In fact, we observed a recruitment of p85 to the
EGFR in response to IAV attachment. One remaining question
would be, whether there is an involvement of additional effector
proteins beyond PI3K, e.g. the E3 ubiquitin ligase c-Cbl, which is
required for progression of EGFR into clathrin coated pits upon
ligand binding [44]. It is likely that a binding site for c-Cbl at the
EGFR will be generated upon IAV attachment and triggers viral
particle sorting into endocytotic pathways upon stimulation. This
hypothesis is supported by recognition of an ubiquitin-vacuolar
protein sorting system for IAV [13] and recruitment of c-Cbl to
the plasma membrane upon EGFR activation [45]. Additional
analyses revealed that also other sites of EGFR-family members
such as Tyr1112 and Ser1113 are phosphorylated upon IAV
attachment similar to EGF stimulation (Figure S4).
In summary, our data provide first evidence for a signaling
regulated uptake of IAV involving activation of RTKs. Multiva-
lent binding of the HA to sialic acids at the cell surface appear to
trigger raft formation, which brings receptor monomers in close
proximity and induce a certain level of RTK activation. This
hypothesis was supported by the finding that SNA binding
mediates EGFR kinase activation since it is described that SNAs
harbour at least two binding sites for sialic acids [30], and
therefore share similarities with the multivalent nature of IAV.
RTK activity in turn leads to activation of intracellular signaling
molecules, such as PI3K that promotes uptake. Because EGFR
and c-Met are only two receptors among many other signaling
receptors that may be activated and may affect the entry of IAV,
the titer reduction in EGFR or c-Met knock-down experiments
was not in the range of log-steps. However, the magnitude of the
effects obtained by functional interference with one or two RTKs
are in line with the mechanism proposed that several RTKs are
involved during virus internalisation. This model is fully supported
experimentally by a simultaneous knock down of c-Met and
EGFR (Figure 4E) or a stepwise inhibition that resulted in additive
effects on viral replication (Figure 4F). However, at the same time
these experiments demonstrate a striking limitation in terms of co-
affecting RTKs with regard to a potential antiviral approach. Just
a limited number of RTKs can be manipulated by chemical
inhibitors or siRNAs at the same time, without interfering with the
viability of cells and thus titer reductions in the range of several log
steps cannot be expected.
In summary, the wide variety of different experiments shown
here, including Western blot analysis, virus internalisation assays
on a single cell level and infection experiments with various MOIs
consistently demonstrate that IAV internalization is promoted by
RTKs, such as the EGFR or c-Met receptor.
at 4uC upon treatment with sialidase (6 sialidase; 0.01 units ml
21, 3 h, 37uC). After a temperature shift cells were further kept at 37uC for the
indicated times. (B) Surface resident EGFR was detected by FACS analysis. Fluorescence of uninfected/-stimulated cells was arbitrarily set as 100%. (C)
After an acidic wash (PBS-HCl, pH 1.3), cells were permeabilized with saponin (0.2% w/v). Infected cells were assessed by detection of viral HA in FACS
analysis. (D, E, F, G) A549 cells were transfected with a control or specific siRNAs targeting caveolin-1 (CAV-1) or clathrin heavy chain (CHC). (D) 48 h
post transfection, knock-down was verified by WB using the indicated antibodies. (E, F) upon knock-down cells were (E) infected with FPV or (F)
incubated with EGF as described in (B), without sialidase treatment. Cell surface EGFR was detected as mentioned in (B). (G) FPV internalization upon
knock-down of the indicated proteins was analysed as described in (C).
doi:10.1371/journal.ppat.1001099.g006
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PLoS Pathogens | www.plospathogens.org 11 September 2010 | Volume 6 | Issue 9 | e1001099Figure 7. EGFR kinase activity is induced upon viral attachment and is required for efficient IAV internalization. (A) A549 cells were
incubated with PD153035 (2.8 mM) or DMSO for 1 h at 37uC and were subsequently treated for 10 min with EGF (30 ng ml
21). PI3K dependent Akt
phosphorlyation (pAktS473) and phosphorylated EGFR (pEGFRY1068) were detected by WB. (B) A549 cells were mock infected [2] or infected with
FPV (MOI=100) [+] for the indicated times at 37uC. In (C and E) cells were treated with sialidase (6 sialidase; 0.01 units ml
21, 3 h, 37uC), and
inoculated with PR8 (MOI=100) for 1 h at 4uC. Subsequently cells were incubated at 37uC for the indicated times. (C, lower panel) The amount of
pEGFR(Y1068) was quantified. Relative pEGFR(Y1068) densities are expressed as mean 6SD of three independent experiments. (D, G) A549 cells were
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Cells, viruses and viral infections
Madin Darby Canine Kidney (MDCK) cells were grown in
MEM, the human lung epithelial cell line A549 and the mouse
embryonic fibroblasts cell line NIH3T3 were grown in DMEM.
Her14 are NIH3T3 cells stably expressing the human wild-type
EGFR [16]. The cell culture media were supplemented with 10%
heat-inactivated fetal bovine serum (FBS) and antibiotics. Cells
were cultured at 37uCa n d5 %C O 2. Avian influenza virus A/
FPV/Bratislava/79 (H7N7) (FPV) and human influenza virus A/
Puerto Rico/8/34 (H1N1) (PR8) were originally provided by the
Institute of Medical Virology in Giessen, Germany. Virus strains
were propagated on MDCK cells supplemented with MEM
without FBS but 0.2% bovine serum albumine and antibiotics;
supernatants were cleared by centrifugation at 6.000 g for
10 min at 4uC, loaded onto a sucrose cushion (20% (w/v)) and
centrifuged at 20.000 g for 3 h at 4uC. IAV was adsorbed as
described in the figure legend. Afterwards, cells were either
washed with PBS or acidic PBS, dependent on the experimental
procedure that is indicated in the figure legend. A harsh acidic
wash (PBS-HCl, pH 1.3 at 4uC) was included to prevent
detection of attached, but not internalized virus particles in the
entry assays. For determination of progeny virus titers, cells were
inoculated with virus for 30 min at 37uC to allow virus
attachment and internalisation. Afterwards a mild acidic wash
(PBS-HCl, pH 5.5 at 4uC) was performed to exclude the delayed
uptake of attached, but not internalized virus particles. Subse-
quently cells were incubated at 37uC for further 8 hours or the
times indicated in the figure legend. Afterwards the supernatant
was taken and the number of infectious virus particles was
determined by standard plaque assay, as described previously
[15]. A pairwise, two-tailed student’s t-test was performed for
statistical comparison between the samples.
infected with PR8 (MOI=4) for 30 min upon pre-treatment with (D) an EGFR inhibitor (10 mM), or (G) PD153035 (2.8 mM) or DMSO for 1 h at 37uC. (E)
EGFR was immuno-precipitated. Co-immunoprecipitated p85 and the input-control was analysed in WB. (F) Cells were stimulated with EGF
(30 ng ml
21) 10 min prior to infection and infected with PR8 (MOI=4) for 30 min at 37uC; an acidic wash (PBS; pH 1.3, 4uC) was performed. WBs were
probed with the indicated antibodies. (H) Biotinylated Sambucus nigra agglutinin (SNA) or Maackia amurensis agglutinin II (MAAII) (1 mgm l
21) were
incubated for 60 min at 4uC with A549 cells. Subsequently cells were either incubated at 37uC for 30 min and lysed for detection of pEGFR(Y1068)
levels by WB or incubated with Cy3-conjugated streptavidin to detect lectins for fluorescence microscopy (scale bar 10 mm). See also Figure S3.
doi:10.1371/journal.ppat.1001099.g007
Figure 8. Model for the RTK-mediated internalization of IAV. In unstimulated cells, RTKs are localized in GM1 positive lipid rafts at the plasma
membrane. Multivalent binding of viral HA to sialic acids at RTKs or GM1 leads to the aggregation of rafts, resulting in the concentration and
clustering of RTK. Intrinsic kinase activity of RTKs is triggered in response to clustering. This leads to signal induction and presumably to the onseto f
endocytosis of the RTKs, which facilitates IAV internalization.
doi:10.1371/journal.ppat.1001099.g008
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The sequence encoding human EGFR, fused to cyan-fluores-
cent protein in pECFP-C1 was kindly provided by Dr. N. Zobiack
(Institute for Medical Biochemistry, ZMBE, Mu ¨nster, Germany).
EGFR-, c-Met-, caveolin-1-, clathrin heavy chain-specific siRNAs
were purchased from Qiagen. Cells were transfected with
Lipofectamine 2000 (Life Technologies) according to a protocol
described previously [46]. The following reagents were purchased
from the suppliers indicated and used as described in the figure
legends: human recombinant EGF (R&D systems Minneapolis,
USA), sialidase (Roche), DMSO and genistein (Sigma-Aldrich,
Germany) a general inhibitor of tyrosine kinases, the EGFR-
blocking antibody (clone O.N. 265) (USBiological), and the EGFR
inhibitors from Calbiochem (#324674, PD153035). Biotinylated
Sambucus nigra agglutinin (SNA), biotinylated Maackia amurensis
agglutinin II (MAAII) and Cy3-conjugated streptavidin were
purchased from Linaris (Wertheim, Germany). The RTK
inhibitor mix contained the following kinase inhibitors: SU4312
(Santa Cruz Biotechnology) targeting plateled derived growth
factor receptor (PDGFR) and vascular endothelial growth factor
receptor (VEGFR), Picropodophyllin (Calbiochem) targeting the
insulin growth factor receptor (IGFR), SU11274 (Calbiochem) a
Met-kinase inhibitor and Gefitinib (Santa Cruz Biotechnology)
that represents an EGFR specific kinase inhibitor (each 10 mM).
Immunoprecipitation and Western-blotting
Immunoprecipitation (IP) and Western-blotting (WB) procedures
were performed as described earlier [6]. For EGFR IP a polyclonal
anti-EGFR antibody (Santa Cruz Biotechnology) and protein A
agarose (Roche) were employed. The viral matrix protein 1 (M1)
was visualized with a mouse monoclonal M1 antiserum (Serotec).
Endogenous and over-expressed EGFR was detected by an EGFR-
specific rabbit antiserum (Cell Signaling Technology). Phosphory-
lated forms of EGFR, Akt and ERK2 were detected by different
phosphospecific antisera: phosphospecific EGFR(Y1068) mouse
antiserum (Cell Signaling Technology), phosphospecific Akt(S473)
rabbit antiserum (Biosource) or phosphospecific ERK1/2 (pT202/
pY204, pT185/pY187) mouse antiserum (Cell Signaling Technol-
ogy). The regulatory subunit p85 of PI3K, was detected by a mouse
monoclonal p85 antiserum (Serotec). In some of the assays, loading
controls were performed with pan-ERK2 antiserum (Santa Cruz
Biotechnology) or pan-Akt antiserum (Cell Signaling Technology).
c-Met was detected by a c-Met specific rabbit antiserum (Santa
Cruz Biotechnology). Knock-down of caveolin-1 and clathrin heavy
chain was verified by WB using a caveolin-1-specific rabbit
antiserum (Santa Cruz Biotechnology) and clathrin heavy chain-
specific mouse antiserum (BD Transduction Laboratories). For
screening of additional phosphorylation sites in the EGFR the
Human EGFR Phosphorylation Antibody Array 1 from RayBio
(USA) was employed according to the manufacturers instructions.
Quantification of Western-blots
Western-blot experiments were quantified using Advanced
Image Data Analyser Software (AIDA, Raytest GmbH, Strau-
benhardt, Germany). The total band densities were measured
against the local background. Obtained values of M1 or
pEGFR(Y1068) were divided through the values of the ERK2
and EGFR loading control, respectively. All data were expressed
as means 6SD of three independent experiments.
Indirect immunofluorescence microscopy
Indirect immunofluorescence microscopy was performed as
described earlier [6]. Top view images were prepared as
compacted Z-Stack images of non-permeabilised cells, using Zeiss
AxioVision software. For colocalization analysis, cells were
examined by confocal laser-scanning microscopy. Quantification
and statistical analysis of colocalization events was calculated as
described in [47]. We used BioImageXD-free open source
software for analysis and visualization of multidimensional
biomedical images (http://www.bioimagexd.net). X-y plane and
z-axis views of confocal images were prepared using ZEN 2009 LE
software from Zeiss, Germany.
Co-patching of lipid rafts with proteins of interest and
colocalization-experiments
FITC-conjugated Choleratoxin beta subunit (CtxB) (Sigma) was
used to visualize raft resident ganglioside M1 (GM1) upon
infection. Subsequently lipid rafts were cross-linked with a rabbit
antiserum against CtxB (Sigma). Samples were incubated for 1 h
at 4uC and subsequently for 15 min at 37uC. EGFR and viral HA
were visualized by the common immunofluorescence staining
protocol. An EGFR specific mouse antiserum (Calbiochem), a
(HA)-specific rabbit antiserum and a H7-HA mouse antiserum,
respectively (kindly provided by H.D. Klenk, University of
Marburg, Germany) were used. Methyl-b-cyclodextrin (MCD)
(Sigma, Aldrich) was used to deplete cholesterol as described
previously [48].
To visualize other proteins in immunofluorescence microscopy
an antibody against the early endosomal antigen 1 (EEA1) (Acris)
and TexasRed labelled transferrin (30 mgm l
21) (Invitrogen) were
used.
Flow cytometry analysis (FACS)
A549 cells were infected with IAV strain FPV or stimulated with
EGF, harvested and prepared for flow cytometry analysis with
FACSCalibur (Becton Dickinson). Cells were washed with cold
PBS, centrifuged for 2 min at 500 g and subsequently incubated
with 1.85% formaldehyde for 20 min at room temperature. For
intracellular protein stains, cells were permeabilized with 0.2% w/
v saponin (Sigma-Aldrich) for 10 min at room temperature. Cells
were treated with 1% fetal calf serum and incubated with an
EGFR specific mouse antiserum (Calbiochem) or an H7-HA
mouse antiserum (kindly provided by H.D. Klenk, University of
Marburg, Germany). After several washing steps, cells were
incubated with an Alexa Fluor 488 chicken anti-mouse IgG (H+L).
Cells were resuspended in PBS and subjected to FACS analysis.
Supporting Information
Figure S1 Transferrin uptake occurs independently from
genistein treatment or EGFR knock-down upon siRNA transfec-
tion. A549 cells were treated with genistein (50 mM) for 60 min
prior to infection (upper panel) or were transfected for 48 h with
control siRNA and specific siRNA targeting EGFR, respectively
(lower panel). Afterwards cells were incubated with TexasRed-
labelled transferrin (30 mg/ml) or EGF (30 ng/ml) for 10 min at
37uC. EGFR was detected by an EGFR-specific mouse antiserum
and EEA1 was detected by an EEA1 rabbit antiserum followed by
a Texas-Red conjugated goat anti-mouse IgG or an Alexa 488-
conjugated chicken anti-rabbit IgG, respectively. Cells were
examined by confocal laser scanning-microscopy. The colocaliza-
tion was quantified as described in the experimental procedure
section.
Found at: doi:10.1371/journal.ppat.1001099.s001 (4.39 MB TIF)
Figure S2 Modulation of the overall EGFR number does not
alter the basal EGFR-signaling. A549 cells were left untransfected
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PLoS Pathogens | www.plospathogens.org 14 September 2010 | Volume 6 | Issue 9 | e1001099(lane 1, 2) or were transfected with siRNA (lane 3, 4) for 48 h or
expression constructs (lane 5, 6) for 24 h hours and subsequently
lysed. Lysates of untransfected cells, which were stimulated with
EGF (30 ng/ml, 10 min) served as positive control (lane 1). WBs
were probed with the indicated antibodies.
Found at: doi:10.1371/journal.ppat.1001099.s002 (0.36 MB TIF)
Figure S3 Cholesterol depletion inhibits IAV-induced EGFR
downstream signaling. A549 cells were left untreated or were
treated with sialidase (0.01 units/ml, 3 h, 37uC). After 2 h
incubation with sialidase, MCD (40 mg/ml) was added in one
untreated and one sialidase treated probe. After incubation for
another hour at 37uC, PR8 (MOI=100) was attached at 4uC for
60 min and subsequently incubated for further 30 min at 37uC,
before cell-lysis. WBs were probed with the indicated antibodies.
Found at: doi:10.1371/journal.ppat.1001099.s003 (0.23 MB TIF)
Figure S4 Screening for additional EGF or virus-induced
phosphorylation sites in EGFR family members. A549 cells were
either left untreated or incubated with EGF (30 ng/ml) or infected
with IAV strain PR8 (MOI=100) for 15 min at 37uC. Cell lysates
were analysed for different phosphosites in different EGFR-family
members, using the Human EGFR Phosphorylation Antibody
Array 1 from RayBio (see material and methods).
Found at: doi:10.1371/journal.ppat.1001099.s004 (0.36 MB TIF)
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